New Genetic Test Guidance Narrows Focus To Mutation Marker Assays
This article was originally published in The Gray Sheet
Executive Summary
FDA is narrowing the focus of its proposed guidelines for manufacturers of gene-based tests from its original 2003 draft in response to comments from industry members and scientists, according to a revised 1draft guidance document issued Feb. 9